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Objective: Jugular paraganglioma (JP) is a rare vascular lesion. Surgical treatment is challenging as
differing degrees of skull base invasion and cranial nerve inﬁltration complicate the procedure. The infra-
temporal fossa type A (IFTA) approach has been advocated as the primary surgical strategy. However, due
to the small number of cases in each report and the different categories of JP, no study has provided
concrete results about the effectiveness and safeness of IFTA in treating different categories of JP.
Methods: We reviewed our institutional experience in the management of patients with JP.
Results: Records of 89 JP patients were reviewed. The IFTA procedure appears equally effective in pre-
serving lower cranial nerve function for both extradural and intracranial extension JP. Use of the IFTA
approach for intracranial JP poses a signiﬁcant risk of post-operative morbidity including facial nerve
dysfunction, tumor recurrence and CSF leak.
Conclusion: Improvements in the standard IFTA approach are necessary for improved outcomes in pa-
tients with intracranial extension JP.
 2013 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Jugular paraganglioma (JP) is a rare neuroendocrine neoplasm
that is mostly slow-growing and benign. The slow growth of JP
often leads to invasion of skull base and inﬁltration of the lower
cranial nerves (LCN), which together with the proximity of major
blood vessels constitute a signiﬁcant challenge to surgical excision.
Despite signiﬁcant strides in recent decades,1 extensive JP con-
tinues to present challenges.
Several treatment strategies have been advocated, but each has
different risk proﬁles with regard to cranial nerve functional
integrity and iatrogenic vascular injury. In an effort to standardize
the surgical management for this disease, Fisch developed a JP
classiﬁcation system and introduced the infra-temporal fossa ap-
proaches (including IFTA).2 Although there are some series
reporting surgical management of JP using the IFTA approach, small
numbers and varying categories of JP make it difﬁcult to reach
conclusions regarding the safety and efﬁcacy of the IFTA approachlogy Head and Neck Surgery,
of Medicine, 1665 Kongjiang
0010.
ng), wuhao@shsmu.edu.cn,
is article.
ciates Ltd. Published by Elsevier Ltin different JP classes. The rarity of JP renders it difﬁcult to establish
a large cohort of patients containing different categories of JP in a
single clinical center.
In this study, we review our 10-year experience in the man-
agement of 89 patients with extensive JP (Fisch type C and D) by the
same surgical team. The clinical history, operative procedures,
radiological and histological features, lower cranial nerve and facial
nerve function results, and post-operative outcome are presented
according to different categories of extensive JP.2. Materials and methods
Ethical approval for this study was given by the Ethical Committee of Xinhua
Hospital. For all patients, we recorded age, gender, presenting symptoms, operative
procedures, exact location and extent of the tumor, clinical classiﬁcation as deter-
mined on the basis of radiological and operative ﬁndings, postoperative outcome, as
well as clinical and radiological follow-up ﬁndings. Facial nerve functionwas graded
according to the HouseeBrackmann scale. The follow-up period ranged from 12 to
120 (mean, 42.7  26.2) months. The extent of tumor was classiﬁed according to the
Fisch classiﬁcation.
Cranial CT scanning was used for all patients to evaluate bony destruction. In
order to estimate tumor blood supply and assess the functional involvement of the
internal carotid artery, angiography and embolizationwere performed. Preoperative
angiography was performed 24e48 h before surgery to avoid development of
collateral vessels for tumor blood supply.
A single-stage tumor removal was adopted in all cases using IFTA approach.
Autologous blood recycle was used in the patients with anticipated signiﬁcant
intraoperative blood loss.d. All rights reserved.
Table 1
Types of previous treatments.
Previous treatment No. of cases
Biopsy 3
Mastoidectomiy without anterior rerouting of FN 9
Neck dissection 4
Infratemporal fossa A approach 1
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3.1. General characteristics and clinical manifestations
Between March 2000 and October 2010, a total of 187 patients
were diagnosed with jugular tumors in Xinhua hospital. Among
these patients, 138 (73.80%) had primary jugular foramen tumors,
of which 89 (64.49%) had extensive jugular paragangliomas. 17
patients had previous treatment, including biopsy, mastoidectomy,
neck dissection and previous IFTA operation (Table 1). Among these
89 patients, 4 were diagnosed with malignant paraganglioma.
There were 56 (62.92%) females and 33 (37.08%) males. The mean
age of surgery was 43  13.6 (range 23e67) years. 47 (52.81%) tu-
mors were on the left side and 42 (47.19%) on the right side. The
extent of tumor to vital structures was categorized according to
Fisch classiﬁcation (Table 2). The tumors type based on radiologic
ﬁnding was as follows: C1, 43 (48.31%); C2, 33 (37.08%); C3, 11
(12.36%); and C4, 2 (2.25%); type De1, 57 (64.04%); De2, 16 (17.98%);
Di1, 12 (13.48%); and Di2, 4 (4.49%). Multiple tumors were found in
6 cases, among which 5 patients had ipsilateral carotid body par-
agangliomas (Fig. 2) and 1 patient had contralateral carotid body
paraganglioma. The most common presenting symptoms included
pulsatile tinnitus (84.27%), hearing loss (77.53%), lower cranial
nerves dysfunction (64.04%), cervical mass (33.71%), external canal
polyp (17.98%), and facial paresis (6.74%) (Table 3).
3.2. Pre-operative angiography
Pre-operative angiography was undertaken in 84 patients. We
found that the ascending pharyngeal artery was the main feeding
artery in 78 patients, while the tumor blood supply in 6 other pa-
tients was the divisions of vertebralartery. A balloon occlusion test
was used when the affected carotid artery might be sacriﬁced ac-
cording to cranial CT scan. 54 patients received balloon occlusion
test to estimate the function of the cerebral cross-perfusion from
the contralateral internal carotid artery (Fig. 1). Only 4 patients
were intolerant of the occlusion test and all these cases were not
recommend for carotid sacriﬁce.
3.3. Surgical treatment, tumor resection and facial nerve
management
Total tumor removal was achieved in 87 patients, while subtotal
removal was achieved in two patients. One of these two patientsTable 2
Extent of the tumor according to Fisch classiﬁcation (N ¼ 89).
Type No. of cases (%)
C1 No or minimal erosion of foramen caroticum 43 (48.31)
C2 Invasion of vertical segment of carotid canal 33 (37.08)
C3 Invasion of horizontal segment of carotid canal 11 (12.36)
C4 Invasion of foramen lacerum and cavernous sinus 2 (2.25)
De1 Extradural extension less than 2 cm in diameter 57 (64.04)
De2 Extradural extension greater than 2 cm in diameter 16 (17.98)
Di1 Intracranial extension less than 2 cm in diameter 12 (13.48)
Di2 Intracranial extension greater than 2 cm in diameter 4 (4.49)was 67 years old with ischemic heart disease and a tumor tightly
adherent to the internal carotid artery. The second patient had a
small residue of tumor surrounded by cavernous sinus, which
ﬁrmly adhered to the tumor. Internal carotid artery integrity was
preserved in 77 patients. Six patients with carotid interruption
underwent direct repair of artery. Five patients received gross
removal of tumor and artery without vessel reconstruction while a
single patient underwent bypass carotid reconstruction following
carotid resection.
Recurrence occurred in 7 cases, among which 3 patients
received radiosurgery, 3 patients with stable residue tumors were
followed-up with annual MRI-Gd, and 1 patient diagnosed with
malignant tumor died 1.5 years after surgery. Tumor recurrence
rate is signiﬁcantly higher in De2 and Di patients comparing with
De1 patients (Table 4).
Facial nerve management included anterior rerouting in 67
cases, partial rerouting in 10 cases and bridge technique in 3 cases.
Nine patients with facial nerve eroded by tumor received gross
removal of tumor and facial nerve. Two of these 9 patients received
facial nerve reconstruction using a sural nerve graft. Of the 7 who
did not undergo facial nerve reconstruction, 6 patients had facial
nerve paresis for more than one year before surgery, and the other
had no identiﬁable proximal nerve (tumor involvement of CPA or
IAC segment). Intracranial extension of tumor resulted in an
increased risk of facial nerve removal (De v.s. Di: 3/73 v.s. 6/16,
P < 0.001, Fisher’s Exact Test).
3.4. Facial nerve status, lower cranial nerve status, and
complications
Preoperatively, 83 (93.26%) of the 89 patients had grade I facial
nerve function. The facial nerve was anatomically preserved in 80
cases. Good facial nerve function (grades I and II) was achieved in
37 (41.57%) of cases, whereas acceptable function (grade III) was
achieved in 30 (33.71%) of cases in 1 year after tumor removal. For
combined postoperative acceptable and better function (grade Ie
III), patients with intracranial extension JP had much lower rates
compared with extradural JP (De v.s. Di: 65/71 v.s. 2/12, P < 0.001,
Fisher’s Exact Test) (Table 4).
Immediately after surgery, none of the patients recovered
function of the preoperatively paralyzed lower cranial nerves. A
new nerve deﬁcit of one or more of the lower cranial nerves was
recorded in 37 patients (Table 5). It should be noted that patients
with intracranial extension JP did not have a higher risk of post-
operative cranial nerve deﬁcit (Table 5). A prophylactic nasogastric
feeding tube was needed in the immediate postoperative period
for those patients who developed deﬁcits of cranial nerve IX and
X. Oral intake was started on the third postoperative day in pa-
tients with preoperative paralysis and on the sixth postoperative
day in the acute paralysis cases. Among the 89 patients, 10 pa-
tients showed no postoperative lower cranial nerve palsy. For the
other 79 patients, the lower cranial nerve dysfunction was
completely compensated in 65 patients after functional speech
and swallowing rehabilitation during follow-up, and 10 patients
had partial cranial nerve function compensation with mild
dysphagia and malnutrition. Vocal cord injection was needed in 13
cases with poor cranial nerve X function. Long-term tube feeding
or stomach ﬁstulization and/or tracheotomy were performed in 4
patients.
Three patients died during follow-up because of malignant
paraganglioma growth, cerebrovascular accident and asphyxia,
respectively. Hemiplegia occurred in 4 patients after surgery, of
whom two recovered completely and two partially after 6 months
of postoperative rehabilitation. CSF leak was also common, occur-
ring in 18 cases. It was resolved by pressure dressings or lumbar
Fig. 1. Embolization and balloon occlusion of jugular paraganglioma. (A) High blood supply tumor in jugular foramen; (B) After embolization of ascending pharyngeal artery; (C)
Balloon occlusion block the infected carotid artery; (D) Cerebral cross-perfusion from contralateral internal carotid artery shows tolerable of the infected carotid sacriﬁce.
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one patient with hydrocephalus received a ventriculo-peritoneal
shunt. Patients with intracranial extension JP had higher rates of
CSF leak (De v.s. Di: 9/73 v.s. 9/16, P < 0.001, Fisher’s Exact Test).Fig. 2. A case of multiple origin paraganglioma. (A) Gd MRI scan shows left jugular paragang
two tumors.4. Discussion
Jugular paragangliomas occur at a rate of approximately one
case per 30,000 individuals.3 The tumor is generally benign, slow-lioma accompanied by a left carotid body paraganglioma; (B) Abundant blood supply of
Table 3
Presenting symptoms/signs in jugular paraganglomas (N ¼ 89).
No. of cases (%)
Pulsatile tinnitus 75 (84.27)
Hearing loss 69 (77.53)
Lower CNS dysfunction 57 (64.04)
Cervical mass 30 (33.71)
External canal polyp 16 (17.98)
Facial paresis 6 (6.74)
Table 5
Classiﬁcation of postoperation effects.
Preop deﬁcit Postop deﬁcit Postop increase
Nerve IX De1 30 (52.6%) 36 (63.2%) 6 (10.5%)
De2 10 (62.5%) 13 (81.2%) 3 (18.8%)
Di1 9 (75%) 10 (83.3%) 1 (8.3%)
Di2 2 (50%) 3 (75%) 1 (25%)
Nerve X De1 21 (36.8%) 39 (68.4%) 18 (31.6%)
De2 9 (56.2%) 11 (68.7%) 2 (12.5%)
Di1 7 (58.3%) 10 (83.3%) 3 (25%)
Di2 0 (0%) 1 (25%) 1 (25%)
Nerve XI De1 6 (10.5%) 7 (12.3%) 1 (1.8%)
De2 6 (37.5%) 8 (50%) 2 (12.5%)
Di1 4 (33.3%) 6 (50%) 2 (16.7%)
Di2 1 (25%) 1 (25%) 0 (0%)
Nerve XII De1 17 (29.8%) 28 (49.1%) 11 (19.3%)
De2 9 (56.2%) 12 (75%) 3 (18.8%)
Di1 7 (58.3%) 9 (75%) 2 (16.7%)
Di2 0 (0%) 1 (25%) 1 (25%)
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ever, it has the potential to invade surrounding skull base structures
and extend intracranially.4,5 As reported previously,6 we found that
malignant JP occurs in w5% of patients (4 out of 89).
The Fisch classiﬁcation focuses on tumor extension to the in-
ternal carotid artery and skull base, which is useful in planning the
clinical management of patients with JP. Extensive involvement of
the internal carotid artery by JP represents a challenging problem
as simultaneous radical tumor resection and preservation of the
vessel often cannot be achieved.7 The possibility of carotid artery
injury must be considered. Careful preoperative imaging including
CT scans and angiography are helpful in deﬁning the anatomic re-
lationships of the tumor to the internal carotid artery.8 Balloon
occlusion testing is useful in predicting patient tolerance of total
occlusion of the internal carotid artery. Though most cases
demonstrate acceptable results on the balloon study of the
contralateral artery, we generally do not recommend carotid sac-
riﬁce.9 An appreciable risk of stroke exists with carotid artery sac-
riﬁce even in cases with favorable functional and occlusion studies.
If possible, repair or graft replacement of the carotid is recom-
mended if the carotid is injured during tumor removal. In some
special cases including elderly patients and patients with neuro-
vascular disease, we prefer subtotal removal of tumor in order to
insure internal carotid artery integrity.
The classic IFTA approach requires rerouting of facial nerve to
optimize exposure.10 Nerve rerouting with surrounding tissues can
maintain the blood supply of nerve ﬁbers and improve post-
operative nerve function. Partial rerouting canbeused in some small
tumors with inferior extent. The bridge technique is rarely used in
extensive JP. In this study, only 3 type C1 tumors with poor blood
supply were amenable to use of the bridge technique. In this series,
the majority of cases involved extradural extension of tumor. While
in the minority, intracranial extension of JP does pose signiﬁcant
risks to preserving facial nerve function. While the majority of De
patients gainedGrade III or better function after facial rerouting (65/
71), signiﬁcantly fewer Di patients achieved acceptable functional
level (2/12). In cases of direct tumor inﬁltration of the facial nerve,
we excised the involved segment and replaced it with a nerve graft
when possible and necessary. The best long-term facial nerve
function in these cases was HouseeBrackmann grade III.
Lower cranial nerve paralysis is a life threatening complication
especially for the patients without preoperative nerve dysfunc-
tion.11 In accordance with others, our results conﬁrmed the difﬁ-
culties in preserving lower CN function immediately after surgery.Table 4
Classiﬁcation of patients.
Fisch
classiﬁcation
Number
of patients
Tumor
recurrence
Facial
nerve
removal
Preoperative
grade I
Postoperative
grade I, II and III
De1 57 0 (0%) 1 (1.8%) 56 55
De2 16 4 (25%) 2 (12.5%) 15 10
Di1 12 2 (16%) 3 (25%) 10 2
Di2 4 1 (25%) 3 (25%) 2 0However, functional speech and swallowing rehabilitation during
follow-up helped 65 patients to gain full functional compensation,
while 10 patients gained partial cranial nerve function compensa-
tion with mild dysphagia and malnutrition. Only 4 patients devel-
oped serious morbidity. We recommend early vocal cord injection
for vagal paralysis. Sudden palsy of previously functioning lower
cranial nerves in elderly patients would cause poor compensation,
which should be taken into consideration in preoperative plan-
ning.12 Some surgeons advocate leaving a small piece of tumor
around the inﬁltratednerves, particularly in the elderly. It is possible
that total removal may entail loss of the nerves involved in the
majority of cases.10 However, based on our results, that most pa-
tients gained satisfactory functional compensation after follow up
rehabilitation, we would suggest carefully dissecting tumor from
nerve to preserve the integrity of lower cranial nerve. In this study,
the IFTA approach is equally effective in preserving lower cranial
nerve function for both extradural and intracranial extension JP. On
the other hand, incomplete removal involves higher risk of recur-
rence.13 In the current series, only 7 patients showed evidence of
tumor recurrence after an average of 42.7 months follow-up.
Postoperative CSF leaks represent another serious complica-
tion.14 CSF leaks can be attributed to the removal of tumors with
both intradural and extracranial extension. We do not propose a
two-stage procedure for such cases because most CSF leaks can be
controlled by conservative management. In our CSF leaks series, 14
cases were cured by pressure dressings or lumbar drainage while 3
cases received surgical repair. Only one case combined with hy-
drocephalus received ventriculo-peritoneal shunt.
While our practice achieved good total tumor clearance, the
postoperative complication rates raise some concerns. There has
been some evidence suggesting more conservative treatment pol-
icies allowing a reduced morbidity.155. Conclusion
Jugular paragangliomas are challenging lesions for lateral skull
base surgeons. As others have reported, surgical removal is the
ideal primary treatment although irradiation is a valid option for
these patients especially in the elderly group. Preoperative imaging
is important for surgical planning. The Fisch classiﬁcation focusing
on extradural or intracranial extension is a good indicator of post-
operative motility and sequelae, including facial nerve function,
tumor recurrence rate, and CSF leak. The IFTA procedure is equally
effective in preserving lower cranial nerve function for both
extradural and intracranial extension JP. We advocate total removal
of tumors since postoperative rehabilitation training could help
Z. Wang et al. / International Journal of Surgery 11 (2013) 853e857 857
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function.
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